{'52WeekChange': -0.52927256,
 'SandP52WeekChange': 0.0644362,
 'address1': '490 Lapp Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 4.54,
 'askSize': 1000,
 'averageDailyVolume10Day': 304812,
 'averageVolume': 576601,
 'averageVolume10days': 304812,
 'beta': 0.788795,
 'beta3Year': None,
 'bid': 4.16,
 'bidSize': 1000,
 'bookValue': -0.52,
 'category': None,
 'circulatingSupply': None,
 'city': 'Malvern',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.31,
 'dayLow': 4.13,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 6.756,
 'enterpriseToRevenue': 1.989,
 'enterpriseValue': 190759808,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 4.6532855,
 'fiftyTwoWeekHigh': 19.21,
 'fiftyTwoWeekLow': 3.987,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 19058317,
 'forwardEps': 0.42,
 'forwardPE': 9.880953,
 'fromCurrency': None,
 'fullTimeEmployees': 213,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.013940001,
 'heldPercentInstitutions': 0.78949,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1574380800,
 'lastSplitFactor': '1115:1000',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/recropharma.com',
 'longBusinessSummary': 'Recro Pharma, Inc. a contract development and '
                        'manufacturing organization, engages in the '
                        'development, manufacturing, and packaging of oral '
                        'solid dose drug products to pharmaceutical market in '
                        'the United States and internationally. The company '
                        'was formerly known as Recro Pharma I, Inc. and '
                        'changed its name to Recro Pharma, Inc. in August '
                        '2008. Recro Pharma, Inc. was founded in 2007 and is '
                        'based in Malvern, Pennsylvania.',
 'longName': 'Recro Pharma, Inc.',
 'market': 'us_market',
 'marketCap': 97797656,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_59223727',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -3263000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.26,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '484 395 2470',
 'previousClose': 4.26,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 1.0194583,
 'profitMargins': -0.25378,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.31,
 'regularMarketDayLow': 4.13,
 'regularMarketOpen': 4.26,
 'regularMarketPreviousClose': 4.26,
 'regularMarketPrice': 4.26,
 'regularMarketVolume': 216286,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 23565700,
 'sharesPercentSharesOut': 0.040900003,
 'sharesShort': 962982,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 868005,
 'shortName': 'Recro Pharma, Inc.',
 'shortPercentOfFloat': 0.0499,
 'shortRatio': 2,
 'startDate': None,
 'state': 'PA',
 'strikePrice': None,
 'symbol': 'REPH',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.069,
 'twoHundredDayAverage': 9.158381,
 'volume': 216286,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.recropharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '19355'}